Skip to main content

Table 1 Patient characteristics summary. Data is given as median (range) for numerical variables and N (%) for categorical variables

From: Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations

Characteristic

Data

Sex (Female/Male)

11/17 (39%/61%)

Age (y)

66 (38–76)

Weight (kg)

88.1 (51.7–129.3)

Diabetes (No/Yes)

22/6 (79%/21%)

Hypertension (No/Yes)

10/18 (36%/64%)

Grade (G1/G2/G3)*

8/15/1 (29%/54%/4%)

ECOG score

1 (0–2)

Number of prior systemic therapies

0 (0–4)

Number of prior liver-directed therapies

0 (0–2)

Estimated glomerular filtration rate (mL/min)

84.6 (31.8–102.7)

Administered 177Lu-DOTATATE (GBq)

7.3 (3.7–7.5)

  1. *Tumor grade was unavailable for 4 (14%) of patients